A Randomized, Double-Blind, Placebo-Controlled, Phase 2 Clinical Trial to Evaluate the Efficacy and Safety of INV-001 Administration for the Prevention of Scar After Thyroidectomy
A Randomized, Double-Blind, Placebo-Controlled, Phase 2 Clinical Trial to Evaluate the Efficacy and Safety of INV-001 Administration for the Prevention of Scar After Thyroidectomy
The goal of this study is to evaluate the efficacy and Safety of INV-001 administration for the prevention of scar after thyroidectomy.
Participants will be asked to apply ointment on their scar for 12 weeks.
to evaluate the efficacy
-investigator check POSAS and VSS
Inclusion Criteria:
Exclusion Criteria:
mjkim@innovothera.com82-2-6956-8680